Helius Medical announces alliance with HealthTech Connex for clinics in Canada
Helius Medical announced that the company has entered into an agreement with HealthTech Connex, or HTC, to develop and manage neuroplasticity clinics in Canada. Both the Portable Neuromodulation Stimulator, or PoNS, device and the NeuroCatch Platform are currently investigational devices, not for sale in Canada or the U.S. PoNS was submitted for review by Health Canada on September 27 and the NeuroCatch Platform is planned to be submitted to Health Canada in Q1 of 2019. Both technologies will be used in Heuro Canada neuroplasticity clinics only if and when those technologies are cleared for use in Canada by Health Canada. Subject to the foregoing, Heuro Canada is anticipated to be operational in Q4.